Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesThe costs of breast cancer in a Mexican public health institution
Risk Management and Healthcare Policy, 07/06/09
Gomez-Rico JA et al. - Breast cancer (BC) is the second leading cause of death as a result of neoplasia in Mexico. The authors found that the total economic burden in the study population was much higher for patients with MRM than for patients with CS.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Presidential order targets improper federal payments
American Hospital Association News, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor